We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PBAX market cap is 36.54M. The company's latest EPS is USD -0.4060 and P/E is -14.41.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.29M | -591k | -1.54M | -430k | -369k |
| Net Income | -263k | -482k | -1.44M | -334k | -283k |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -332k | -2.91M | -2.93M |
| Net Income | -316k | -668k | -2.54M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 42.37M | 14.43M | 14.11M | 8.47M | 8.56M |
| Total Liabilities | 39.9M | 12.44M | 13.56M | 13.95M | 14.32M |
| Total Equity | -10.76M | -11.58M | -13.29M | -13.77M | -14.2M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 180.08M | 42.37M | 8.56M |
| Total Liabilities | 9.25M | 39.9M | 14.32M |
| Total Equity | -7.67M | -10.76M | -14.2M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -1.09M | -198k | -1.08M | -1.34M | -1.52M |
| Investing | 180.84M | -100k | 185k | 5.87M | -7.95M |
| Financing | -138.7M | N/A | 525k | -4.89M | -32.58M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -697k | -1.09M | -1.52M |
| Investing | -178.5M | 180.84M | -7.95M |
| Financing | 180.3M | -138.7M | -32.58M |
| Market Cap | 36.54M |
| Price to Earnings Ratio | -14.41 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 377.42 |
| Price to Book Ratio | -6.34 |
| Dividend Yield | - |
| Shares Outstanding | 6.25M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -45.58% |
| 52 Week High | 12.80 |
| 52 Week Low | 4.12 |
| Spread (Intraday) | 0.85 (14.53%) |
| Company Name | Phoenix Biotech Aquisition Corporation |
| Address |
rodney square wilmington, delaware 19801 |
| Website | https://www.cero.bio/ |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
